Nov. 2023 Podcasts: Australia-China uneasy partnership, end for value investing

Below is a summary of the topics we covered on Nucleus Investment Insights this month. See the links for more information.
Damien Klassen

Nucleus Wealth

A Reluctant Embrace: The Australia-China Uneasy Partnership

In this podcast, Nucleus Wealth's Chief Investment Officer, Damien Klassen, and Head of Advice, Samuel Kerr, revisited the tense relations with our largest trading partner.

Prime Minister Albanese is in China this week. The Australia-China trade relationship has been fraught with tension, stemming from a complex interplay of geopolitical rivalry, human rights concerns, and security issues. Australia’s push for an inquiry into the origins of COVID-19, and its outspoken criticism of China’s actions in Hong Kong and Xinjiang, led to diplomatic strains, with China retaliating by imposing tariffs and import restrictions on key Australian exports like barley, wine, and beef.

Furthermore, China’s increasing assertiveness in the South China Sea and its economic coercion tactics have triggered a defensive response from Australia, leading to calls for diversification of trade partnerships and a reevaluation of reliance on the Chinese market. The once mutually beneficial economic ties now face the challenges of trust deficit and ideological clashes, complicating the prospects of smooth trade relations.

Watch the episode here.

Is It The End For Value Investing?


The last few year’s of performance suggests there are some serious problems with value investing. In recent weeks, share market volatility has re-emerged, and many investors are expecting Value to protect them – but Value has failed to do so in recent years. Will this time be any different?

In this podcast, Nucleus Wealth’s Chief Investment Officer, Damien Klassen and Head of Advice, Samuel Kerr take a hard look at the problems with Value investing and what investors should expect.

Watch the episode here.

Agenda

  • How is value performing (spoiler: bad)
  • What is value
  • What went wrong
  • Have we got measurement error
  • How I think about value

Why Is Excess Mortality Still High, What Does It Mean For Insurers?

Years after the COVID-19 pandemic has subsided, excess mortality is still way higher than usual in countries all around the world.

Suicides, cancer, COVID-19 and heart disease are all running above average.

In this podcast, Nucleus Wealth's Chief Investment Officer, Damien Klassen, delves into what that means for life insurers and broader investments.

Agenda:

  • Excess Deaths: Background
  • Over and under
  • Insurers. Hit hard, but not terrible. Now repricing.
  • Obesity drugs: Background
  • Why
  • How
  • When

Watch the episode here.

The Weight Is Over: Capitalising on the Booming Weight Loss Drug Industry

In this podcast, Nucleus Wealth’s Chief Investment Officer Damien Klassen, Senior Investment Analyst Radek Zeleny, and Head of Advice Samuel Kerr delve into the fast-growing market of weight loss drugs, exploring the latest trends, breakthroughs, and market dynamics.

We provide an in-depth analysis of the top players in the industry, including established pharmaceutical giants and innovative startups that are shaking up the scene. We explore the efficacy and safety of these booming weight loss drugs, what new treatments are on the horizon and how to profit from this trend.

Watch the episode here.

An Investor’s Guide to 3rd Quarter Earnings


In this week’s podcast, Nucleus Wealth’s Chief Investment Officer, Damien Klassen, and Head of Advice, Samuel Kerr, delve into the complex landscape of 3rd quarter earnings.

The overall trend shows a downgrade in earnings forecasts, signalling a cautious approach by many companies. However, amidst this general downtrend, there exists a noteworthy exception – a group dubbed “The Magnificent 7”. These stocks have not only defied the broader market sentiment but have also showcased remarkable resilience and growth potential.

As we dissect these earnings reports, we observe that the market, while grappling with immediate uncertainties, continues to hold a surprisingly optimistic outlook for 2024. This optimism seems rooted in the belief that current challenges are temporary and that a stronger economic environment is on the horizon.

Watch the episode here.

........
The information on this blog contains general information and does not take into account your personal objectives, financial situation or needs. Past performance is not an indication of future performance. Damien Klassen is an authorised representative of Nucleus Wealth Management, a Corporate Authorised Representative of Nucleus Advice Pty Ltd - AFSL 515796.

Damien Klassen
Head of Investment
Nucleus Wealth

Damien runs asset allocation and global stock portfolios for Nucleus Super, Nucleus Ethical and Nucleus Wealth. His 25 year+ career includes Global Quant at Schroders, Strategy at Wilson HTM & co-founder of Aegis.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment